Paiteling induces apoptosis of cervical cancer cells by down-regulation of the E6/E7-Pi3k/Akt pathway: A network pharmacology.
Autor: | Liu Y; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Zheng P; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Jiao T; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Zhang M; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Wu Y; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Zhang X; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Wang S; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China., Zhao Z; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: zongjiangz@sina.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of ethnopharmacology [J Ethnopharmacol] 2023 Apr 06; Vol. 305, pp. 116062. Date of Electronic Publication: 2022 Dec 17. |
DOI: | 10.1016/j.jep.2022.116062 |
Abstrakt: | Ethnopharmacological Relevance: Human papillomavirus (HPV) infection is considered to be the main pathogen causing intraepithelial neoplasia. Paiteling (PTL) has been used to treat intraepithelial neoplasia caused by human papillomavirus (HPV) infection for more than 20 years in China, but its specific mechanism of action is not very clear, and further research is still needed. Objective: This study designed a comprehensive strategy to study the pharmacological mechanism of paiteling in regulating cervical cancer cell apoptosis by integrating LC-MS/MS, network pharmacology and pharmacological experiments. Methods: We used liquid chromatography-tandem mass spectrometry to detect the active substances in PTL and performed protein-protein interaction analysis on the intersection of the targets of these key compounds and the targets of intraepithelial neoplasia. Additionally, by using Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes (KEGG), the potential pathway of PTL against HPV-induced intraepithelial neoplasia was predicted. Finally, we used HeLa and Ect1/E6E7 cells for experimental verification. Results: The protein-protein interaction network predicted that AKT1, TP53, MYC, STAT3, MTOR, and MAPK were pivotal targets for PTL to inhibit epithelial neoplasia. KEGG enrichment analysis showed that the Pi3k/Akt pathway and HPV infection had scientific significance. Compared to the control group, after PTL diluent stimulated HeLa and Ect1/E6E7 cells for 24 h, cell viability, migration, and invasion capabilities were significantly reduced, and cell apoptosis was significantly increased, conforming to a dose-effect relationship and time-effect relationship. PCR, cellular immunohistochemistry, and western blot experiments showed that PTL reduced the expression of E6, Pi3k, E7, Akt, Bcl-xl, while increasing the expression of Bad in HeLa and Ect1/E6E7 cells. Conclusion: PTL can induce cervical cancer cell apoptosis by inhibiting the E6/E7-Pi3k/Akt signaling pathway. It may provide an effective alternative strategy of traditional Chinese medicine for the treatment of epithelial neoplasia caused by HPV infection. Competing Interests: Declaration of competing interest The authors declare no conflict of interest. We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted. (Copyright © 2022. Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |